Medmonitor

An up-to-date timeline of U.S. Food and Drug Administration (FDA) approvals that could potentially impact workers' compensation. These include new drug and indication approvals, new dosages or formulations of existing products, and generics introduced to the market. Click through the interactive timeline below, or select the comprehensive list view.

← Back to Medmonitor

Medication Type: Muscle Relaxant

Muscle Relaxant

Atmeksi (methocarbamol) oral solution

Approval Date: Jul 2025

Note: New Product

A muscle relaxant indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions

Medication Name

Approval Date

Description

Atmeksi (methocarbamol) oral solution

Jul 2025

Muscle Relaxant

A muscle relaxant indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions

Note: New Product